title: Whole body MRI and PET/CT in haematological malignancies.
abstract: The usefulness of whole body magnetic resonance imaging (MRI) and positron emission tomography (PET)/computed tomography (CT) in haematological malignancies is reviewed. PET/CT combining functional and anatomical information is currently a valuable tool in the management of patients with lymphoma, especially in the assessment of early treatment response. MRI is advantageous in evaluating bone marrow involvement and therefore plays an important role in clinical decision making for patients with myeloma. The development of whole body functional MR studies is underway and can potentially complement the PET/CT for better patient care.
authors.affiliation: Department of Radiology, Centre Hospitalo-Universitaire Henri Mondor, 51, Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France.
authors.forename: Chieh
authors.initials: C
authors.lastname: Lin
authors.forename: Alain
authors.initials: A
authors.lastname: Luciani
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Itti
authors.forename: Corinne
authors.initials: C
authors.lastname: Haioun
authors.forename: Alain
authors.initials: A
authors.lastname: Rahmouni
mesh_terms: D003287:Contrast Media; D019337:Hematologic Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging; D006801:Humans; D008279:Magnetic Resonance Imaging; D011379:Prognosis; D019275:Radiopharmaceuticals; D018570:Risk Assessment; D014055:Tomography, Emission-Computed; D014057:Tomography, X-Ray Computed; D051598:Whole Body Imaging
chemical_list: D003287:Contrast Media; D019275:Radiopharmaceuticals